Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
168.3 USD | -0.74% | +2.48% | +8.62% |
Apr. 23 | US CDC warns of harmful reactions to fake Botox injections | RE |
Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
Financials (USD)
Sales 2024 * | 54.57B | Sales 2025 * | 57.78B | Capitalization | 300B |
---|---|---|---|---|---|
Net income 2024 * | 9.08B | Net income 2025 * | 11.09B | EV / Sales 2024 * | 6.48 x |
Net Debt 2024 * | 53.67B | Net Debt 2025 * | 45.01B | EV / Sales 2025 * | 5.97 x |
P/E ratio 2024 * |
30.6
x | P/E ratio 2025 * |
25.1
x | Employees | 50,000 |
Yield 2024 * |
3.69% | Yield 2025 * |
3.84% | Free-Float | 96.75% |
Latest transcript on AbbVie Inc.
1 day | -0.89% | ||
1 week | +2.76% | ||
Current month | -7.31% | ||
1 month | -5.46% | ||
3 months | +2.78% | ||
6 months | +15.36% | ||
Current year | +8.91% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | 0.00% | - | |
6.85% | 18 M€ | +4.24% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 168.3 | -0.73% | 1 313 183 |
24-04-23 | 169.5 | +0.98% | 4,084,105 |
24-04-22 | 167.9 | +0.89% | 5,580,685 |
24-04-19 | 166.4 | +1.06% | 5,532,492 |
24-04-18 | 164.7 | +0.25% | 4,480,224 |
Delayed Quote Nyse, April 24, 2024 at 10:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.91% | 300B | |
+25.84% | 672B | |
+25.83% | 570B | |
-5.78% | 360B | |
+16.03% | 321B | |
+6.87% | 217B | |
-9.24% | 204B | |
+5.53% | 199B | |
-8.98% | 149B | |
-4.93% | 147B |
- Stock Market
- Equities
- ABBV Stock